IV Loop Diuretics

Pre-clinicalRecruiting
0 watching 0 views this week๐Ÿ’ค Quiet
15
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Heart Failure (for Example, Fluid Overload)

Conditions

Heart Failure (for Example, Fluid Overload), Heart Failure, Fluid Overload

Trial Timeline

Jun 28, 2022 โ†’ Dec 31, 2026

About IV Loop Diuretics

IV Loop Diuretics is a pre-clinical stage product being developed by Nuwellis for Heart Failure (for Example, Fluid Overload). The current trial status is recruiting. This product is registered under clinical trial identifier NCT05318105. Target conditions include Heart Failure (for Example, Fluid Overload), Heart Failure, Fluid Overload.

Hype Score Breakdown

Clinical
5
Activity
2
Company
2
Novelty
2
Community
1

Clinical Trials (1)

NCT IDPhaseStatus
NCT05318105Pre-clinicalRecruiting

Competing Products

20 competing products in Heart Failure (for Example, Fluid Overload)

See all competitors
ProductCompanyStageHype Score
IV diureticNuwellisPre-clinical
15
Stepped pharmacologic careNuwellisPhase 3
69
IV Loop Diuretics (LD)NuwellisPre-clinical
15
TRV120027 + Normal SalineTrevenaPhase 1
25
TRV027 Dose #1 + TRV027 Dose #2 + TRV027 Dose #3 + PlaceboTrevenaPhase 2
44
TRV120027 + PlaceboTrevenaPhase 1/2
33
Ilofotase alfa + PlaceboAM-PharmaPhase 2
44
INXN-4001PrecigenPhase 1
28
LY3461767 + PlaceboEli LillyPhase 1
33
SGLT2i, beta blocker, ARNI, MRA, MTDEli LillyApproved
85
Pactimibe, CS-505Daiichi SankyoPhase 2
52
Prasugrel 10 mg daily x 2 weeks + Clopidogrel 75 mg daily x 2 weeksDaiichi SankyoApproved
85
olmesartan medoxomil + candesartan cilexetil placebo + olmesartan medoxomil placebo + candesartan cilexetilDaiichi SankyoPhase 3
77
OlmesartanDaiichi SankyoPhase 3
77
Carperitide + PlaceboDaiichi SankyoPhase 2
52
EdoxabanDaiichi SankyoPre-clinical
23
RegadenosonAstellas PharmaPhase 1
33
Advagraf + PrografAstellas PharmaPhase 2
52
FK506EAstellas PharmaPhase 3
77
ConivaptanAstellas PharmaApproved
85